A reliable and applicable record states the opposite.
Johnson & Johnson said in December 2018 that its baby powder is safe and asbestos-free.
Johnson & Johnson’s baby powder is safe and asbestos-free.
- About
- Johnson & Johnson
- Claim made by
- Johnson & Johnson, company statement
- Published
- 14 December 2018
- Evidence score
- 76 How it was scored
- Last reviewed
- 25 October 2026
Why this label
The statement was categoricalS1. Ten months later FDA said a sample from one lot contained chrysotile asbestosS6. The company notice puts the level at no greater than 0.00002% in one bottle bought onlineS2. J&J recalled lot 22318RBS2. The FDA record states the opposite of asbestos-free for that product lot. J&J said it could not confirm whether the sample was cross-contaminated or whether the bottle was authentic, and it repeated that its talc does not contain asbestosS2. That dispute lowers the score, but the company offered no finding that the FDA result was wrong. The record contradicts the absolute claim. It does not show how widespread any contamination was.
Current procedural position
Company statement of 14 December 2018S1. Voluntary recall of one lot announced on 18 October 2019, completed and terminated by FDAS2.
Record supporting the assessment
A sample from this lot was found to contain chrysotile fibers, a type of asbestos.
sub-trace levels of chrysotile asbestos contamination (no greater than 0.00002%)
Conflicting or limiting record
Johnson & Johnson’s baby powder is safe and asbestos-free.
Studies show talc is safe, does not contain asbestos and does not cause cancer.
Evidence score: 76 of 100
The score grades how well the record establishes this assessment. It is not a score of Johnson & Johnson. Score = source authority + directness + corroboration + procedural accuracy + currency + reproducibility.
| Component | Points | Max | Reason |
|---|---|---|---|
| Source authorityIs the source competent to establish the proposition? | 25 | 30 | FDA's own notice states the test result for the product lot. |
| DirectnessDoes the source state the proposition or only discuss adjacent facts? | 16 | 20 | The record names chrysotile asbestos in the tested product. |
| CorroborationDo independent records support the same material point? | 8 | 15 | The FDA notice and the company recall notice agree, but only one lot is documented. |
| Procedural accuracyDoes the record settle the procedural state the claim describes? | 9 | 15 | The recall is completed, but J&J disputes the sample. |
| CurrencyHas the record been checked against later developments? | 9 | 10 | Checked against J&J's July 2026 statement, which keeps the same position. |
| ReproducibilityCan a reader locate the passage and repeat the assessment? | 9 | 10 | Both pages are public. |
| Total | 76 | 100 |
Timeline
Responses
- Johnson & Johnson Consumer Inc., 18 October 2019: The company said it could not confirm whether the FDA sample was cross-contaminated or the product authentic.S2
Revision history
- Assessment first published with label Contradicted.
Have a record that changes this assessment? See corrections and responses.
Sources
- S6Tier A Baby Powder Manufacturer Voluntarily Recalls Product for AsbestosUS Food and Drug Administration. Regulator press release. 18 October 2019.FDA's own notice that a sample from lot 22318RB contained chrysotile asbestos in its cosmetics survey. It covers one lot and says a sample from another lot tested negative.Link working, checked 25 October 2026
- S2Tier B Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby Powder in the United StatesUS Food and Drug Administration (company announcement). Company statement. 18 October 2019.Company recall notice posted by FDA, reporting the FDA test result for one lot. FDA says it posts such notices as a public service and does not endorse the company.Link working, checked 25 October 2026
- S1Tier B Statement on Reuters Talc ArticleJohnson & Johnson. Company statement. 14 December 2018.J&J's rebuttal of the Reuters report. It is the company's position, not a finding.Link working, checked 25 October 2026
- S5Tier B Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc LitigationJohnson & Johnson. Company statement. 27 July 2026.Announces a proposed US$5.5 billion resolution and repeats J&J's safety position. It describes the MDL order but is not a court record.Link working, checked 25 October 2026
Other claims about Johnson & Johnson
- Partly supported55A Reuters investigation in December 2018 reported that Johnson & Johnson knew for decades that asbestos was at times found in its talc and talc powders.Press report, 14 December 20184 records citedProduct claims
- Outdated86Johnson & Johnson said in September 2024 that its subsidiary Red River Talc LLC had filed a prepackaged Chapter 11 case to resolve all current and future ovarian cancer talc claims.Company statement, 20 September 20244 records citedCorporate status
- Unresolved48Johnson & Johnson said in July 2026 that studies show talc does not cause cancer.Company statement, 27 July 20263 records citedProduct claims